New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 14, 2014
07:03 EDTACORAcorda names Andrew Hindman as Chief Business Development Officer
Acorda Therapeutics has appointed Andrew Hindman as Chief Business Development Officer. Hindman has held several senior executive level positions in the biopharmaceutical industry, most recently as President, CEO and member of the Board of Tobira Therapeutics, a privately-held biotechnology company.
News For ACOR From The Last 14 Days
Check below for free stories on ACOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
11:07 EDTACORAcorda sues Mylan over plans to duplicate Ampyra MS drug, Bloomberg says

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use